Form 4 for INSM INSMED Inc
Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-08 · accession 0001628280-24-001036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-10 | 2024-01-08+ | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $29.32 | -55.0K | 373.5K | -13% | -$1.61M |
| DM | 2024-01-10 | 2024-01-08 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $20.49 | +45.1K | 398.5K | +13% | +$924.5K |
| D | 2024-01-10 | 2024-01-08 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $20.49 | +45.1K | 0 | New | +$924.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-08 | S | D | 24,951 | $29.11 | 373,538 | D | — | — | (F2) This is the weighted average sales price representing 24,951 shares sold at prices ranging from $28.71 to $29.68 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2024-01-09 | S | D | 9,887 | $28.72 | 363,651 | D | — | — | (F5) This is the weighted average sales price representing 9,887 shares sold at prices ranging from $28.62 to $28.84 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2024-01-08 | S | D | 20,169 | $29.88 | 373,538 | D | — | — | (F3) This is the weighted average sales price representing 20,169 shares sold at prices ranging from $29.88 to $29.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2024-01-08 | M | A | 20,169 | $20.49 | 393,707 | D | — | — | |
| 5 | Common | Common Stock | 2024-01-08 | M | A | 24,951 | $20.49 | 398,489 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-01-08 | M | A | 45,120 | $20.49 | 0 | D | $20.49 · — to 2024-01-10 | 45,120 Common Stock | (F6) Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. All options are currently exercisable and were scheduled to expire on January 10, 2024. |